Annovis Stock Future Price Prediction

ANVS -  USA Stock  

USD 9.14  0.20  2.24%

Annovis Bio stock price prediction is an act of determining the future value of Annovis Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Annovis Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Annovis Bio and does not consider all of the tangible or intangible factors available from Annovis Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Annovis Bio, which may create opportunities for some arbitrage if properly timed.
Please continue to Annovis Bio Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Annovis Bio based on different types of headlines from major news networks to social media. The Annovis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Annovis Bio over a specific investment horizon. Using Annovis Bio hype-based prediction, you can estimate the value of Annovis Bio from the perspective of Annovis Bio response to recently generated media hype and the effects of current headlines on its competitors.
Annovis Bio Book Value per Share is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Book Value per Share of 5.83. As of 05/26/2022, Current Ratio is likely to grow to 32.94, while Earnings per Diluted Share are likely to drop (2.05) .
This module is based on analyzing investor sentiment around taking a position in Annovis Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Annovis Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Annovis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Annovis Bio after-hype prediction price

    
  $ 8.61  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Annovis Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Annovis Bio in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
8.0524.0328.54
Details
Naive
Forecast
LowNext ValueHigh
3.938.4512.96
Details
1 Analysts
Consensus
LowTarget PriceHigh
70.0070.0070.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
8.399.3610.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Annovis Bio. Your research has to be compared to or analyzed against Annovis Bio's peers to derive any actionable benefits. When done correctly, Annovis Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Annovis Bio.

Annovis Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Annovis Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Annovis Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Annovis Bio, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Annovis Bio Estimiated After-Hype Price Volatility

In the context of predicting Annovis Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Annovis Bio's historical news coverage. Annovis Bio's after-hype downside and upside margins for the prediction period are 4.10 and 13.12, respectively. We have considered Annovis Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 9.14
8.61
After-hype Price
13.12
Upside
Annovis Bio is not too volatile asset. Analysis and calculation of next after-hype price of Annovis Bio is based on 3 months time horizon.

Annovis Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Annovis Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Annovis Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Annovis Bio, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
  0.61  4.53   0.31    0.07  5 Events / Month1 Events / MonthIn about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
9.148.613.69 
888.24  

Annovis Bio Hype Timeline

Annovis Bio is presently traded for 9.14. The entity has historical hype elasticity of -0.31 and average elasticity to hype of competition of -0.07. Annovis is anticipated to decline in value after the next headline with price expected to drop to 8.61. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -3.69% whereas the daily expected return is presently at -0.61%. The volatility of related hype on Annovis Bio is about 4118.18% with expected price after next announcement by competition of 9.07. About 31.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Annovis Bio recorded a loss per share of 1.4. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipatedpress releasewill be in about 5 days.
Please continue to Annovis Bio Basic Forecasting Models to cross-verify your projections.

Annovis Bio Related Hype Analysis

Having access to credible news sources related to Annovis Bio's direct competition is more important than ever and may enhance your ability to predict Annovis Bio's future price movements. Getting to know how Annovis Bio rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Annovis Bio may potentially react to the hype associated with one of its peers.

Annovis Bio Additional Predictive Modules

Most predictive techniques to examine Annovis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Annovis using various technical indicators. When you analyze Annovis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Annovis Bio Predictive Indicators

The successful prediction of Annovis Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Annovis Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Annovis Bio based on analysis of Annovis Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Annovis Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Annovis Bio's related companies.

Story Coverage note for Annovis Bio

The number of cover stories for Annovis Bio depends on current market conditions and Annovis Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Annovis Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Annovis Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Contributor Headline

Latest Perspective on Annovis Bio

Annovis Bio Short Properties

Annovis Bio's future price predictability will typically decrease when Annovis Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Annovis Bio often depends not only on the future outlook of the potential Annovis Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Annovis Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.12%
Short Percent Of Float3.07%
Float Shares5.64M
Shares Short Prior Month279.58k
Average Daily Volume Last 10 Day32.22k
Average Daily Volume In Three Month40.96k
Date Short Interest29th of April 2022
Please continue to Annovis Bio Basic Forecasting Models to cross-verify your projections. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.